Peruvian Man Suffers Guillain-Barré-like Symptoms After Receiving Sinopharm COVID-19 Vaccine

Peruvian Man Suffers Guillain-Barré-like Symptoms After Receiving Sinopharm COVID-19 Vaccine

On Dec. 11, 2020, Peru’s National Institute of Health (INS) said it was temporarily suspending the Phase 1 clinical trial of an experimental COVID-19 vaccine developed by Sinopharm Group Co. Ltd. of Shanghai, China after one of the participants in the trial who got the vaccine showed difficulty in moving his arms and legs—symptoms of Guillain-Barré syndrome (GBS).1 2 3 4 5

Peru’s Health Service Suspends Clinical Trial of Sinopharm COVID-19 Vaccine

In a public statement, the INS said that the “adverse event” was “under investigation to determine if it is related to the vaccine or if there is another explanation.”4 5

“Several days ago we signaled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome,” said German Malaga, MD, chief researcher at Cayetano Heredia University in Lima, Peru, where the vaccine trial is being conducted. “We are concerned about the situation, and we are providing all of our help and support to ensure that it is cleared up,” he said.1 2 3

Guillain-Barre Syndrome After Vaccination

During 1976, as part of a campaign by the U.S. government to vaccinate Americans against a novel type A strain of the influenza virus known as H1N1 (“swine flu”), 450 people in the United States developed Guillain-Barre syndrome (GBS), which involved inflammation of the peripheral nervous system and can cause temporary or permanent paralysis that can be fatal.1 2 6

According to referenced information on the website of the National Vaccine Information Center (NVIC) at NVIC.org:

One of the most serious documented influenza vaccine reactions is Guillain-Barre syndrome (GBS). An immune mediated painful and disabling neurological disorder that can occur after viral infection or vaccination, GBS involves inflammation of the peripheral nervous system and can cause temporary or permanent paralysis that may lead to death. GBS usually develops within two to four weeks of vaccination.7

NVIC notes that GBS is characterized by “muscle weakness, unsteady gait, numbness, tingling, pain.” It can cause “paralysis of the face or one or more limbs” and can take “several months for recovery or it can leave the affected person with chronic health problems and disability.”7

The U.S. Food and Drug Administration (FDA) lists GBS as one of 22 possible “adverse events outcomes” that are being monitored after people receive new COVID-19 vaccinations.8 The other vaccine adverse events on the FDA’s surveillance list include:

  • acute disseminated encephalomyelitis
  • transverse myelitis
  • encephalitis/myelitis/encephalomyelitis/meningoencephalitis/meningitis/encepholapathy
  • convulsions/seizures
  • stroke
  • narcolepsy and cataplexy
  • anaphylaxis
  • acute myocardial infarction
  • myocarditis/pericarditis
  • autoimmune disease
  • deaths
  • pregnancy and birth outcomes
  • other acute demyelinating diseases
  • non-anaphylactic allergic reactions
  • thrombocytopenia
  • disseminated intravascular coagulation
  • venous thromboembolism
  • arthritis and arthralgia/joint pain
  • Kawasaki disease
  • multisystem inflammatory syndrome in children
  • vaccine enhanced disease.

Sinopharm’s COVID-19 Vaccine Uses Killed Virus

Unlike COVID-19 vaccines produced by companies such as Pfizer, Inc. (and its partner BioNTech SE) and Moderna, Inc. that rely on a novel vaccine technology that uses synthetic messenger RNA (mRNA) designed to instruct cells in the human body to produce proteins and stimulate the production of SARS CoV-2 antibodies, Sinopharm’s COVID-19 vaccine uses traditional vaccine technology incorporating a killed SARS CoV-2 virus to deliver the vaccine.9

Suspension is Lifted

Peruvian health minister Pilar Mazzetti, MD announced on Dec. 16 that Sinopharm could resume its clinical trial in Peru even though it was unclear why the trial volunteer developed GBS. “We have had several meetings with Sinopharm and the suspension has been lifted,” Dr. Mazzeti said.10 


Click here to view References:

5 Responses to "Peruvian Man Suffers Guillain-Barré-like Symptoms After Receiving Sinopharm COVID-19 Vaccine"

  1. Tom   December 22, 2020 at 12:55 pm

    Vaccines can cause paralysis in at least two ways:

    1) nerve poisons in the vaccines (aluminum, mercury, formaldehyde, etc) can attack the nervous system directly (much like the original Polio was caused by nerve-poison pesticides like DDT starting in the late 1800s, and later added to by toxic vaccines… it was never, despite years of horrific experiments by virologists, shown to have anything to do with any virus. Much like ‘sars-cov-2,’ the ‘polio virus’ was never isolated, characterized, proven to exist, much less proven to be harmful, much less proven to be infectious).

    2) an autoimmune reaction caused by the massive over-activation of the immune system by the poisonous adjuvants in vaccines (like aluminum, which also happens to be a neurotoxin). The immune system gets revved up to a chaotic state, much like kicking a bee nest, and in that state might attack anything– including your own body tissues. In the case of paralysis, the nerves and brain.

    You have to hand it to the virology-vaccinology cult that they turned this side effect of their own products (and those of the pesticide poison industry) into a huge PR win with ‘Polio.’ Part of the brilliance of their strategy was creating a bunch of new classifications for paralysis to replace ‘Polio’ as mentioned in this article: Guillain-Barre, acute flaccid paralysis, transverse myelitis, Bells Palsy, etc.

    These are all really the same thing: destruction of the insulating myelin sheathes around the nerves, leading to paralysis. But by more strictly redefining them by, for example, location (face, arms, etc), Pharma created a bunch of new paralysis diseases so the numbers of any one of them look smaller (and they can pretend Polio Myelitis has ‘disappeared’ thanks to their poisons).

    Instead of ‘this vaccine caused 1000 cases of paralysis’ they can say ’10 cases of Guillain Barre, 12 cases of Transverse Myelitis, etc etc.’ Basically they can hide the horrific paralysis they are causing.

    Pretty brilliant. Pretty evil.

    Reply
  2. Kimberly   December 22, 2020 at 2:37 pm

    SinopHARM

    Reply
  3. Bruce   December 22, 2020 at 2:59 pm

    I had gotten Guillian Barre after Swine flu vaccine in 1976 . Total paralyzed.

    Reply
  4. JennyM   December 22, 2020 at 9:19 pm

    These reactions won’t scare the dumbed down sheep very much, those who will take the toxic swill are the same ones who take the drugs that have black box warnings on them and advertised on TV that quickly go through side effects like cancer, necrosis of your skin, heart attack, and death. Anyone who blindly trusts allopathic medicine with their health will get this vaccine.

    Reply
  5. Mary Ann   December 28, 2020 at 4:34 pm

    My father contracted GBS in 1982 after receiving the flu shot. He had a year in hours of sick leave built up as a civilian worker at Luke AFB. He was one of the healthiest people I knew. Laid in ICU 3 days to the year of being admitted fully paralyzed and on a ventilator.

    Reply

Leave a Reply

Your email address will not be published.